Department of Health and Social Care written question – answered at on 15 October 2018.
To ask the Secretary of State for Health and Social Care, with reference to the £200 million allocated to the Cancer Transformation Funding, how much funding each Cancer Alliance (a) received in (i) 2017-2018 and (ii) 2018-2019; and (b) how much such funding remains outstanding.
To ask the Secretary of State for Health and Social Care, with reference to the Cancer Transformation Fund, when he plans to publish the provisional allocation of the £29.7 million of capital expenditure classified by NHS England as not yet approved.
NHS England is allocating £200 million transformation funding in 2017/18 and 2018/19 to support Cancer Alliances to deliver improvements in faster and earlier diagnosis and quality of life for people living with a cancer diagnosis. Over £72 million was released in 2017/18 to support Cancer Alliances to transform cancer services. A further £9 million went to Greater Manchester to support its Cancer Alliance, as part of a devolution agreement.
For 2018/19, the allocation for each Cancer Alliance is as follows:
Cancer Alliance | Total Funding (£) |
Northern | 6,991,000 |
West Yorkshire and Harrogate | 5,410,000 |
3,445,000 | |
Cheshire and Merseyside | 5,552,000 |
Lancashire and South Cumbria | 3,307,000 |
Humber, Coast and Vale | 3,764,000 |
Greater Manchester | 14,500,000 |
18,103,000 | |
8,842,000 | |
16,094,000 | |
5,369,000 | |
Kent and Medway | 2,301,000 |
Surrey and Sussex | 3,128,000 |
5,084,000 | |
Peninsula | 3,179,000 |
Wessex | 7,282,000 |
2,764,000 | |
RM Partners | 12,048,000 |
UCLH Cancer Collaborative | 11,130,000 |
Pan-London | 2,832,000 |
141,125,000 |
The figures above include both the revenue and capital funding allocated to each Alliance.
Yes1 person thinks so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.